রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন।
GLIKAZID MR 60MG Tablet is indicated for:
Type 2 Diabetes Mellitus: Effective for controlling blood sugar levels in adults whose diabetes is not adequately managed by diet, exercise, and lifestyle modifications.
Gliclazide is a second-generation sulfonylurea that stimulates pancreatic beta cells to release insulin. Its modified-release formulation ensures steady and prolonged glycemic control, reducing blood sugar spikes.
Dosage:
Start with 30mg or 60mg once daily. Adjust dose based on glycemic response up to 120mg daily.
Administration:
Take orally with water during breakfast. Swallow the tablet whole without crushing or chewing.
Increased Risk of Hypoglycemia: With alcohol, other antidiabetic drugs, or beta-blockers.
Decreased Effectiveness: With corticosteroids, diuretics, or hormonal contraceptives.
Hypersensitivity to Gliclazide or other sulfonylureas.
Type 1 diabetes or diabetic ketoacidosis.
Severe liver or kidney impairment.
Common: Hypoglycemia, dizziness, headache, and nausea.
Rare: Allergic reactions, gastrointestinal upset, or liver function abnormalities.
Pregnancy: Not recommended; insulin is the preferred treatment during pregnancy.
Lactation: Not advised as it may pass into breast milk.
Monitor blood glucose levels regularly to avoid hypoglycemia.
Use with caution in elderly patients and those with renal or hepatic impairment.
Avoid skipping meals to reduce the risk of hypoglycemia.
Sulfonylurea (Antidiabetic).
Store below 30°C in a cool, dry place.
Protect from light and moisture.
Keep out of reach of children.